grant

A novel target in aged fracture healing

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 30 Sept 2023Deadline 31 May 2028
NIHUS FederalResearch GrantFY20257S Gamma GlobulinAPOEAffectAgeAgingAntibodiesApo-EApoE proteinApolipoprotein EBM Stem CellBM derived progenitorBM progenitorBM- derived Stem CellsBiologyBody TissuesBone Marrow Stem CellBone Marrow progenitorBone RegenerationBone TissueBone callusBony CallusCallusCell Communication and SignalingCell Culture TechniquesCell SignalingCell Surface ReceptorsCell surfaceCirculationClinicDataDepositDepositionDoseElderlyFractureFracture HealingHealthHepatic CancerHepatic CellsHepatic Parenchymal CellHepatocyteHumanIgGImmunoglobulin GImpairmentIn VitroInjuryInterventionIntracellular Communication and SignalingLigandsLiteratureLiverLiver CellsLoxP-flanked alleleMUSK geneMalignant neoplasm of liverMechanicsMiceMice MammalsModelingModern ManMorbidityMorbidity - disease rateMouse Homolog of Receptor Tyrosine Kinase NSK2MurineMusMuscle, Skeletal, Receptor Tyrosine KinaseMuscle-Specific KinaseMyoneural JunctionNSK2Neuromuscular JunctionOperative ProceduresOperative Surgical ProceduresOrthopedicOrthopedic Surgical ProfessionOrthopedicsOsteoblastsOutcomePTK ReceptorsPathway interactionsPatientsPhenotypePhosphorylationPopulationProtein PhosphorylationProteinsPublic HealthPublishingReceptor ProteinReceptor Protein-Tyrosine KinasesReceptor Tyrosine Kinase GeneReceptor Tyrosine Kinase MuSKRegimenReportingRoleShort interfering RNASignal PathwaySignal TransductionSignal Transduction SystemsSignalingSmall Interfering RNASurgicalSurgical InterventionsSurgical ProcedureTestingTherapeuticTimeTissuesTranscriptTransgenic MiceTranslatingTransmembrane Receptor Protein Tyrosine KinaseTreatment ProtocolsTreatment RegimenTreatment ScheduleTyrosine Kinase Linked ReceptorsTyrosine Kinase ReceptorsWorkadvanced ageage associatedage correlatedage dependentage linkedage relatedage specificagedaged boneaged miceaged mouseagesbiological signal transductionbonebone agingbone fracturebone fracture healingbone fracture repairbone healingbone marrow derived progenitorbone marrow derived stem cellsbone marrow stromal cellbone marrow stromal stem cellbone repairbone wound healingcell culturecell culturesclinical translationclinically translatablecohortcostdeliver short interfering RNAdeliver siRNAdeliver small interfering RNAdelivery system for siRNAdelivery system for small interfering RNAdelivery vectors for siRNAdevelop therapyelderly micefloxedfloxed allelefracture repairgeriatrichealth care burdenhepatic body systemhepatic organ systemimprovedinduced Creinducible Creinhibitorinjuriesintervention developmentknock-downknockdownliver cancerliver malignancymalemalignant liver tumormechanicmechanicalmineralizationmortalitymouse Cre recombinasemouse modelmurine modelneutralizing antibodynovelold miceolder adultolder adulthoodoptimal therapiesoptimal treatmentsosseous wound healingosteoblast cell differentiationosteoblast differentiationosteoblast progenitorosteoblast stem cellosteoblastic differentiationosteogenicosteogenic progenitorosteogenic stem cellosteoprogenitorosteoprogenitor cellpathwaypre-clinicalpreclinicalpreventpreventingprotein expressionreceptorregenerate bonescRNA sequencingscRNA-seqsenior citizenshort interfering RNA deliverysiRNAsiRNA deliverysingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsmall interfering RNA deliverysocial rolesurgerytherapeutic targettherapy developmenttissue culturetreatment development
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

ABSTRACT
Bone fractures occur in 50% of the population causing significant morbidity and mortality and costing more than

$20 billion annually. Advanced age diminishes bone repair capacity and is associated with increased surgical

intervention at the time of the injury and subsequently with the need for revisions. The development of therapies

aimed…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
A novel target in aged fracture healing — DUKE UNIVERSITY | UNITED STATES | Sept 2023 | Dev Procure